HADV — Health Advance Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.27m
- $0.31m
- $0.02m
Annual income statement for Health Advance, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2014 July 31st | 2015 July 31st | 2016 July 31st | 2020 March 31st | 2021 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | PROSPECTUS | PROSPECTUS |
Standards: | USG | USG | USG | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0.01 | 0.02 |
Cost of Revenue | |||||
Gross Profit | 0 | 0 | 0 | — | — |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 0.072 | 0.067 | 0.029 | 0.008 | 0.042 |
Operating Profit | -0.072 | -0.067 | -0.029 | 0.002 | -0.022 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.072 | -0.068 | -0.029 | 0.022 | 0.017 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.072 | -0.068 | -0.029 | 0.022 | 0.017 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.072 | -0.068 | -0.029 | 0.022 | 0.017 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.072 | -0.068 | -0.029 | 0.022 | 0.017 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.003 | -0.003 | -0.001 | 0 | 0 |
Dividends per Share |